EquityZen Growth Technology Fund LLC - Series 1238
Raised
$930K
Investors
39
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1238 is a Delaware pre-IPO pooled investment vehicle filed by EquityZen Advisors LLC and related parties, raising $930K from 39 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This amended filing is part of the EquityZen platform, which operates 1,889 related EDGAR entities providing secondary liquidity for private company shares.
This is a typical pre-IPO fund exemption structure combining 506(b) private placement with 3(c)(1) Investment Company Act exclusion, common for secondary market platforms. The $10K minimum investment represents a retail-accessible tier compared to traditional pre-IPO vehicles that often require $100K+ minimums, consistent with EquityZen's democratized access model.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
